Grail (GRAL) Cash & Equivalents (2023 - 2026)
Grail's (GRAL) quarterly Cash & Equivalents came in at $55.6 million in Q2 2026, down 56.33% on a YoY basis from $127.4 million in Q2 2025, and down 19.76% quarter-over-quarter from $69.3 million in Q1 2026.
Analysis
Grail (GRAL) Cash & Equivalents (2023 - 2026) Analysis & Trends
Grail (GRAL) has reported Cash & Equivalents for 4 consecutive years, with $55.6 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Cash & Equivalents fell 56.33% year-over-year to $55.6 million; the trailing twelve-month figure through Jun 2026 stood at $55.6 million (down 56.33% YoY), and the FY2025 full-year result was $249.7 million, up 16.57% from the prior year.
- Cash & Equivalents declined to $55.6 million in Q2 2026 per GRAL's latest filing, from $69.3 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $958.8 million in Q2 2024 and bottomed at $55.6 million in Q2 2026.
- Historically, Cash & Equivalents has averaged $266.2 million across 4 years, with a median of $143.8 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Cash & Equivalents surged 493.41% in 2024, then sank 86.71% in 2025.
- Over 4 years, Cash & Equivalents stood at $97.3 million in 2023, then jumped by 120.21% to $214.2 million in 2024, then advanced by 16.57% to $249.7 million in 2025, then tumbled by 77.72% to $55.6 million in 2026.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $55.6 million, $69.3 million, and $249.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | 1.10 Bn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | 626.00 Mn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 141.80 Mn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | 1.05 Bn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | 599.61 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | 690.92 Mn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 356.72 Mn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 548.63 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | 169.87 Mn |
| 10 | Grail | 3.61 Bn | 2.75 Bn | 21.34 Mn | 55.65 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 55.65 Mn |
| Mar 31, 2026 | 69.34 Mn |
| Dec 31, 2025 | 249.73 Mn |
| Sep 30, 2025 | 126.90 Mn |
| Jun 30, 2025 | 127.43 Mn |
| Mar 31, 2025 | 133.90 Mn |
| Dec 31, 2024 | 214.23 Mn |
| Sep 30, 2024 | 853.55 Mn |
| Jun 30, 2024 | 958.85 Mn |
| Mar 31, 2024 | 199.72 Mn |
| Dec 31, 2023 | 97.29 Mn |
| Oct 1, 2023 | 143.84 Mn |
| Jun 30, 2023 | 230.62 Mn |